Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
November 17, 2009
Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?
Pierre-Emmanuel Morange, David-Alexandre Tregouet
The New England Journal of Medicine
|
July 9, 2008
Cholesterol gene polymorphisms and cardiovascular events
Laurence Tiret, David-Alexandre Tregouet, François Cambien
Atherosclerosis
|
November 18, 2005
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Isabelle Chevrier, David-Alexandre Tregouet, Simone Massonnet-Castel, et al.
Genome Research
|
August 7, 2003
Automated detection of informative combined effects in genetic association studies of complex traits
Nadia Tahri-Daizadeh, David-Alexandre Tregouet, Viviane Nicaud, et al.
Biomolecules
|
January 17, 2020
Design and Rationale of the ERA-CVD Consortium PREMED-CAD-Precision Medicine in Coronary Artery Disease
Apurva Shrivastava, Vincenzo Marzolla, Henri Weidmann, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
April 15, 2011
A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project
Ciara Vangjeli, Patrick Dicker, David-Alexandre Tregouet, et al.
Human Molecular Genetics
|
August 8, 2002
Specific haplotypes of the P-selectin gene are associated with myocardial infarction
David-Alexandre Tregouet, Sandrine Barbaux, Sylvie Escolano, et al.
Circulation Research
|
October 8, 2005
Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction
Eve Pearce, David-Alexandre Tregouet, Ann Samnegård, et al.
Blood
|
May 18, 2006
Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study
Corinne Frère, David-Alexandre Tregouet, Pierre-Emmanuel Morange, et al.
Thrombosis and Haemostasis
|
August 23, 2005
Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact
Corinne Frère, Pierre Emmanuel Morange, Noémie Saut, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
November 17, 2009
Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?
Pierre-Emmanuel Morange, David-Alexandre Tregouet
The New England Journal of Medicine
|
July 9, 2008
Cholesterol gene polymorphisms and cardiovascular events
Laurence Tiret, David-Alexandre Tregouet, François Cambien
Atherosclerosis
|
November 18, 2005
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Isabelle Chevrier, David-Alexandre Tregouet, Simone Massonnet-Castel, et al.
Genome Research
|
August 7, 2003
Automated detection of informative combined effects in genetic association studies of complex traits
Nadia Tahri-Daizadeh, David-Alexandre Tregouet, Viviane Nicaud, et al.
Biomolecules
|
January 17, 2020
Design and Rationale of the ERA-CVD Consortium PREMED-CAD-Precision Medicine in Coronary Artery Disease
Apurva Shrivastava, Vincenzo Marzolla, Henri Weidmann, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
April 15, 2011
A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project
Ciara Vangjeli, Patrick Dicker, David-Alexandre Tregouet, et al.
Human Molecular Genetics
|
August 8, 2002
Specific haplotypes of the P-selectin gene are associated with myocardial infarction
David-Alexandre Tregouet, Sandrine Barbaux, Sylvie Escolano, et al.
Circulation Research
|
October 8, 2005
Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction
Eve Pearce, David-Alexandre Tregouet, Ann Samnegård, et al.
Blood
|
May 18, 2006
Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study
Corinne Frère, David-Alexandre Tregouet, Pierre-Emmanuel Morange, et al.
Thrombosis and Haemostasis
|
August 23, 2005
Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact
Corinne Frère, Pierre Emmanuel Morange, Noémie Saut, et al.
Page
of 6